EXHIBIT 6.2 November 24, 1999 Mr. Randal J. Kirk Chairman Clinical Chemistry Holdings, Inc. 7335 Lee Highway Radford, VA 24141 Dear Mr. Kirk: The letter agreement between Albert Investment Strategies, Inc. ("Albert"), Clinical Chemistry Holdings, Inc....Letter Agreement • December 6th, 1999 • Kirk Randal J • Laboratory analytical instruments
JOINT FILING AGREEMENTJoint Filing Agreement • December 6th, 1999 • Kirk Randal J • Laboratory analytical instruments
In accordance with Rule 13d-1(f) promulgated under the Securities Exchange Act of 1934, as amended, the persons names below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Novitron International, Inc., and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 6th day of December, 1999.
EXHIBIT 6.1 November 12, 1999 Mr. Randal J. Kirk Chairman Clinical Chemistry Holdings, Inc. 7335 Lee Highway Radford, VA 24141 Dear Mr. Kirk: This letter shall represent our legally binding agreement as follows: 1. Effective November 12, 1999 (the...Stock Transfer Agreement • December 6th, 1999 • Kirk Randal J • Laboratory analytical instruments • Florida
